NCT06412666Phase 2, phase 3Active not recruiting

A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2030-01Estimated

Enrollment · participants65Estimated

Source updated2026-08-18Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-08-18 · 2 fields changed

Planned enrollment increased by 10 participants

− Before

~~55 participants (planned)~~

+ After

65 participants (planned)

Recruitment status changed

− Before

~~Recruiting~~

+ After

Active not recruiting

Check registry source

Posted 2025-11-12 · 1 field changed

Planned enrollment increased by 15 participants

− Before

~~40 participants (planned)~~

+ After

55 participants (planned)

Check registry source